New studies should be planned to further explore and validate the role of CXCR4 as a possible therapeutic target or a predictor of response in patients of all ages with chronic rhinitis, pharyngitis or sinusitis undergoing thermal water nasal inhalations. This evidence concerns the gene CXCR4 and chronic rhinitis.